Pramiconazole

Pramiconazole
Clinical data
ATC code	none;
Identifiers
	IUPAC name 1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one;
PubChem CID	3013050; 11411233;
ChemSpider	2281806 ;
UNII	4SYH0R661F;
ChEMBL	CHEMBL175797 ;
Chemical and physical data
Formula	C35H39F2N7O4
Molar mass	659.725 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F;
	InChI InChI=1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1 ; Key:AEKNYBWUEYNWMJ-QWOOXDRHSA-N ;
(what is this?) (verify)

Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections.

It is developed by Barrier Therapeutics.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

Clinical data

ATC code	none
Identifiers
IUPAC name 1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one
PubChem CID	3013050 11411233
ChemSpider	2281806^N
UNII	4SYH0R661F
ChEMBL	CHEMBL175797^N
Chemical and physical data
Formula	C₃₅H₃₉F₂N₇O₄
Molar mass	659.725 g/mol
3D model (JSmol)	Interactive image
SMILES CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F
InChI InChI=1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1^N Key:AEKNYBWUEYNWMJ-QWOOXDRHSA-N^N
^NY (what is this?) (verify)